In the broadest research project to date, Israel's Clalit health network tested the results of the fourth vaccine doze on patients suffering from COVID-19.
The study indicates that the vaccine decreases chances of dying from the virus by 76%.
It also revealed that a fourth doze decreases symptomic illness by 61%, and serious virus cases by 64%.